Search Results - "Glassman, Alexander"

Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death by Glassman, Alexander H., Bigger, J. Thomas

“…OBJECTIVE: The authors review the mechanisms and establish the risk of torsade de pointes and sudden death with antipsychotic drugs. METHOD: They present a…”
Get full text

Schizophrenia, antipsychotic drugs, and cardiovascular disease by Glassman, Alexander H

“…Since the early 1980s, concern within the psychiatric community about whether antipsychotics are associated with adverse cardiovascular events has grown. In…”
Get full text

Depression and cardiovascular comorbidity by Glassman, Alexander H.

“…Depression has long had a popular link to cardiovascular disease and death. However, only during the last 15 years has scientific evidence supporting this…”
Get full text

Smoking cessation and the course of major depression: a follow-up study by Glassman, Alexander H, Covey, Lirio S, Stetner, Fay, Rivelli, Sarah

“…Smokers with a history of major depression who attempt to stop smoking have a higher risk of failure than non-depressed smokers. Anecdotal and post-hoc data…”
Get full text

Depression and the Course of Coronary Artery Disease by Glassman, Alexander H., Shapiro, Peter A.

“…Literature and folk wisdom have long linked depression and death; however, only recently have scientific studies examined the relation between them. Beginning…”
Get full text

Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina by Glassman, Alexander H, O'Connor, Christopher M, Califf, Robert M, Swedberg, Karl, Schwartz, Peter, Bigger, Jr, J. Thomas, Krishnan, K. Ranga Rama, van Zyl, Louis T, Swenson, J. Robert, Finkel, Mitchell S, Landau, Charles, Shapiro, Peter A, Pepine, Carl J, Mardekian, Jack, Harrison, Wilma M, for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group

“…CONTEXT Major depressive disorder (MDD) occurs in 15% to 23% of patients with acute coronary syndromes and constitutes an independent risk factor for morbidity…”
Get full text

Where There Is Depression, There Is Inflammation․․․Sometimes by Glassman, Alexander H, Miller, Gregory E

Get full text

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy by Serebruany, Victor L, Glassman, Alexander H, Malinin, Alex I, Nemeroff, Charles B, Musselman, Dominique L, van Zyl, Louis T, Finkel, Mitchell S, Krishnan, K Ranga R, Gaffney, Michael, Harrison, Wilma, Califf, Robert M, O'Connor, Christopher M

“…Depression after acute coronary syndromes (ACSs) has been identified as an independent risk factor for subsequent cardiac death. Enhanced platelet activation…”
Get full text

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report by Davidson, Karina W, Kupfer, David J, Bigger, J Thomas, Califf, Robert M, Carney, Robert M, Coyne, James C, Czajkowski, Susan M, Frank, Ellen, Frasure-Smith, Nancy, Freedland, Kenneth E, Froelicher, Erika S, Glassman, Alexander H, Katon, Wayne J, Kaufmann, Peter G, Kessler, Ronald C, Kraemer, Helena C, Krishnan, K Ranga R, Lespérance, François, Rieckmann, Nina, Sheps, David S, Suls, Jerry M

“…The National Heart, Lung, and Blood Institute convened an interdisciplinary working group of experts to develop recommendations for the assessment and…”
Get full text

Depression Severity and Effect of Antidepressant Medications by Glassman, Alexander H

Get full text

The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised by Bigger, J Thomas, Glassman, Alexander H

“…The American Heart Association issued a science advisory on depression and coronary heart disease (CHD) in 2008. This paper reviews the purpose and content of…”
Get full text

A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse by Covey, Lirio S., Glassman, Alexander H., Jiang, Huiping, Fried, Jane, Masmela, Jenny, LoDuca, Catherine, Petkova, Eva, Rodriguez, Kristina

“…ABSTRACT Aim  To investigate the efficacy of maintenance treatment with bupropion and/or nicotine gum for reducing smoking relapse. Design, setting and…”
Get full text

Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome by Swenson, J.Robert, O'Connor, Christopher M, Barton, David, Van Zyl, Louis T, Swedberg, Karl, Forman, Leslie M, Gaffney, Michael, Glassman, Alexander H

“…Major depressive disorders complicate recovery from acute coronary syndrome in approximately 1 in 5 patients, and have been found to be associated with…”
Get full text

Antidepressants in Coronary Heart Disease: SSRIs Reduce Depression, But Do They Save Lives? by Glassman, Alexander H, Bigger, J. Thomas

“…The efficacy of citalopram and interpersonal psychotherapy in the treatment of major depression in patients primarily free of coronary heart disease (CHD) is…”
Get full text

Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action by O’Brien, Charles P., Charney, Dennis S., Lewis, Lydia, Cornish, James W., Post, Robert M., Woody, George E., Zubieta, Jon-Kar, Anthony, James C., Blaine, Jack D., Bowden, Charles L., Calabrese, Joseph R., Carroll, Kathleen, Kosten, Thomas, Rounsaville, Bruce, Childress, Anna Rose, Oslin, David W., Pettinati, Helen M., Davis, Mark A., DeMartino, Robert, Drake, Robert E., Fleming, Michael F., Fricks, Larry, Glassman, Alexander H., Levin, Frances R., Nunes, Edward V., Johnson, Robert L., Jordan, Clarence, Kessler, Ronald C., Laden, Sally K., Regier, Darrel A., Renner, John A., Ries, Richard K., Sklar-Blake, Thomas, Weisner, Constance

Get full text

Relationship Between Release of Platelet Endothelial Biomarkers and Plasma Levels of Sertraline and N-Desmethylsertraline in Acute Coronary Syndrome Patients Receiving SSRI Treatment for Depression by Serebruany, Victor L., Suckow, Raymond F., Cooper, Thomas B., O'Connor, Christopher M., Malinin, Alex I., Krishnan, K. Ranga R., van Zyl, Louis T., Lekht, Vladimir, Glassman, Alexander H., Sertraline Antidepressant Heart Attack Randomized Trial

“…OBJECTIVE: In a platelet endothelial biomarker substudy of the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART), the authors sought to…”
Get full text

A Randomized Trial of Sertraline as a Cessation Aid for Smokers With a History of Major Depression by Covey, Lirio S., Glassman, Alexander H., Stetner, Fay, Rivelli, Sarah, Stage, Kurt

“…OBJECTIVE: Evidence that major depression can be a significant hindrance to smoking cessation prompted this examination of the usefulness of sertraline as a…”
Get full text

Smokers’ Response to Combination Bupropion, Nicotine Patch, and Counseling Treatment by Race/Ethnicity by Covey, Lirio S., Botello-Harbaum, Maria, Glassman, Alexander H., Masmela, Jenny, LoDuca, Catherine, Salzman, Victoria, Fried, Jane

“…Evidence on how to tailor nicotine dependence treatment to specific race/ethnic groups is limited. The present study investigated responses to established…”
Get full text

Smoking, Smoking Cessation, and Major Depression by Glassman, Alexander H, Helzer, John E, Covey, Lirio S, Cottler, Linda B, Stetner, Fay, Tipp, Jayson E, Johnson, Jim

“…A relationship between cigarette smoking and major depressive disorder was suggested in previous work involving nonrandomly selected samples. We conducted a…”
Get full text

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia by Roose, S P, Glassman, A H, Attia, E, Woodring, S

“…The popularity of selective serotonin reuptake inhibitors stems from their apparent efficacy for numerous disorders and their favorable side effect profile…”
Get more information